We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants

By HospiMedica International staff writers
Posted on 28 Jun 2022

The SARS-CoV-2 Omicron variant has demonstrated rapid spread but with reduced disease severity. More...

Patients with Omicron infection have half the odds of hospitalization and of severe disease than those infected with Delta and preceding variants. Furthermore, the risk of being admitted to hospital for Omicron infection is 65% lower for vaccinated compared to unvaccinated individuals. However, there is limited data on differential severity and outcomes between variants once patients are admitted to hospital for SARS-COV-2. A recent study had demonstrated that vaccinated patients with SARS-COV-2 ‘breakthrough’ infections show fewer chest CT findings of pneumonia compared with unvaccinated patients, although variant status in this study was unknown. Now, a new study has found that the SARS-COV-2 Omicron variant is associated with fewer and less severe changes on chest CT compared with the Delta variant. The study also found that patients with Omicron had greater frequency of bronchial wall thickening but lower clinical severity and improved hospital outcomes than those with Delta.

In a retrospective analysis, researchers at the Oxford University Hospitals NHS Foundation Trust (Oxford, UK) compared the radiological pattern, imaging characteristics and disease severity on initial CT pulmonary angiograms of patients infected with the Omicron variant with those infected with the Delta variant, as well as compared the imaging severity according to vaccination status.

In a small series of hospitalized patients who had tested RT-PCR positive for SARS-CoV-2 with CT pulmonary angiography performed within seven days of admission, the researchers found that the Omicron variant infection is less likely to be associated with SARS-CoV-2 pneumonia, and that, when pneumonia does occur, it is less severe on chest CT. In agreement with chest CT patterns, Omicron infection was associated with reduced clinical and biochemical markers of severity and improved hospital outcomes. The researchers found lower CT severity scores (7.2) and increased incidence of bronchial wall thickening in the Omicron group. In terms of vaccination status, those who were vaccinated also recorded lower CT severity scores. These findings were consistent, regardless of the interpreting radiologist’s experience level.

Related Links:
Oxford University Hospitals NHS Foundation Trust


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.